RESUME

Celgene Corporation

Application Filed: 2010-05-25
Trademark Application Details
Trademark Logo RESUME

Mark For: RESUME® trademark registration is intended to cover the categories of medical and scientific research, including conducting clinical trials; conducting clinical trials on the safety and effectiveness of lenalidomide; clinical trials on the safety and effectiveness of a drug for multiple myleloma.

Status

2023-12-26 UTC
DEAD REGISTRATION Cancelled Invalidated
The trademark application was registered, but subsequently it was cancelled or invalidated and removed from the registry.


Research OneLook Acronym Finder
Serial Number85047318
Registration Number3940196
Mark Literal ElementsRESUME
Mark Drawing Type4 - STANDARD CHARACTER MARK
Mark TypeService Mark
Current LocationTMEG LAW OFFICE 102 2016-06-13
Basis1(a)
Class StatusSECTION 8 - CANCEL
Primary US Classes
  • 100: Miscellaneous
  • 101: Advertising and Business
Primary International Class
  • 042 - Primary Class
  • (Computer, scientific & legal) Scientific and technological services and research and design relating thereto: industrial analysis and research services; design and development of computer hardware and software; legal services.
Filed UseNo
Current UseYes
Intent To UseNo
Filed ITUYes
44D FiledYes
44E CurrentNo
66A CurrentNo
Current BasisNo
No BasisNo
Attorney NameCamille M. Miller
Attorney Docket Number271288 / CEL
Law Office AssignedL20
Employee NameSAITO, KIM TSUKIYO

Timeline

2010-05-25Application Filed
2010-07-15Date of First Use
2010-07-15Date of Use In Commerce
2011-01-18Published
2011-01-18Published for Opposition
2011-04-05Trademark Registered
2016-06-13Location: TMEG LAW OFFICE 102
2016-06-13Status: Live/Registered
2018-07-08Transaction Date
2021-11-19Cancelled
2021-11-19Status: Registration cancelled because registrant did not file an acceptable declaration under Section 8. To view all documents in this

Trademark Parties (Applicants & Owners)

Party: Celgene Corporation
Address86 Morris Avenue Summit, NEW JERSEY UNITED STATES 07901
Legal Entity TypeCorporation
Legal Entity StateDELAWARE

Documents

ApplicationAPPLICATION/XML,IMAGE/JPEG2010-05-25
DrawingIMAGE/JPEG2010-05-25
Notation to FileAPPLICATION/XML2010-07-20
Offc Action OutgoingAPPLICATION/XML2010-07-20
XSearch Search SummaryAPPLICATION/XML2010-07-20
Examiners AmendmentAPPLICATION/XML2010-07-22
Suspension LetterAPPLICATION/XML2010-07-22
Amendment and Mail Process CompleteAPPLICATION/XML,IMAGE/JPEG2010-07-23
Amendment to Allege UseAPPLICATION/XML,IMAGE/JPEG2010-11-09
SpecimenIMAGE/JPEG2010-11-09
TEAS Response to Suspension InquiryAPPLICATION/XML2010-11-09
Amendment and Mail Process CompleteAPPLICATION/XML,IMAGE/JPEG2010-11-10
TRAM Snapshot of App at Pub for OppostnAPPLICATION/XML,IMAGE/JPEG2010-11-11
AAU Processing CompleteAPPLICATION/XML,IMAGE/JPEG2010-12-15
Notice of Acceptance of AAUAPPLICATION/XML2010-12-15
TRAM Snapshot of App at Pub for OppostnAPPLICATION/XML,IMAGE/JPEG2010-12-15
Publication & Issue Review CompleteAPPLICATION/XML,IMAGE/JPEG2010-12-16
Notice of PublicationAPPLICATION/XML2011-01-18
Registration CertificateIMAGE/JPEG2011-04-05
Change of AddressAPPLICATION/XML2015-07-29
Courtesy E-Reminder of Sec. 8 (6-yr)APPLICATION/XML2016-04-05
Section 8 and 15APPLICATION/XML,IMAGE/JPEG,IMAGE/TIFF2016-04-05
SpecimenIMAGE/JPEG2016-04-05
Notice of Acceptance AcknowledgementAPPLICATION/XML2016-06-13
Courtesy E-Reminder of Sec. 8/Sec. 9APPLICATION/XML2020-04-05

Attorney of Record

CAMILLE M. MILLER
COZEN O'CONNOR
1650 MARKET ST, Suite 2800
One Liberty Place
PHILADELPHIA, PA 19103

Good, Services, and Codes

International Codes:42
U.S. Codes:100,101
Type CodeType
GS0421medical and scientific research, including conducting clinical trials; conducting clinical trials on the safety and effectiveness of lenalidomide; clinical trials on the safety and effectiveness of a drug for multiple myleloma

Trademark Filing History

DescriptionDateProceeding Number
CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 92021-11-19
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED2020-04-05
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.2016-06-13
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED2016-06-13
CASE ASSIGNED TO POST REGISTRATION PARALEGAL2016-06-13
TEAS SECTION 8 & 15 RECEIVED2016-04-05
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED2016-04-05
TEAS CHANGE OF CORRESPONDENCE RECEIVED2015-07-29
REGISTERED-PRINCIPAL REGISTER2011-04-05
PUBLISHED FOR OPPOSITION2011-01-18
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED2011-01-18
NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED2010-12-15
LAW OFFICE PUBLICATION REVIEW COMPLETED2010-12-15
USE AMENDMENT ACCEPTED2010-12-14
APPROVED FOR PUB - PRINCIPAL REGISTER2010-12-14
AMENDMENT TO USE PROCESSING COMPLETE2010-12-14
PREVIOUS ALLOWANCE WITHDRAWN-TIMELY AAU2010-12-09
ASSIGNED TO LIE2010-11-23
APPROVED FOR PUB - PRINCIPAL REGISTER2010-11-10
USE AMENDMENT FILED2010-11-09
TEAS/EMAIL CORRESPONDENCE ENTERED2010-11-09
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED2010-11-09
TEAS AMENDMENT OF USE RECEIVED2010-11-09
CORRESPONDENCE RECEIVED IN LAW OFFICE2010-11-09
SUSPENSION LETTER WRITTEN2010-07-22
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED2010-07-22
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED2010-07-22
LETTER OF SUSPENSION E-MAILED2010-07-22
EXAMINERS AMENDMENT E-MAILED2010-07-22
EXAMINERS AMENDMENT -WRITTEN2010-07-22
EXAMINER'S AMENDMENT ENTERED2010-07-22
NOTIFICATION OF NON-FINAL ACTION E-MAILED2010-07-20
NON-FINAL ACTION WRITTEN2010-07-20
NON-FINAL ACTION E-MAILED2010-07-20
ASSIGNED TO EXAMINER2010-07-12
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED2010-05-28
NEW APPLICATION ENTERED2010-05-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed